In the meantime, here are all the expert-led CPD certified sessions from our virtual event in June, for a flavour of what to expect in 2022!
09 Jun 2021
-
Keynote
Delivering our Long Term Plan commitments and completing the job of pandemic recovery are two sides of the same coin – both require cancers being identified faster and earlier, improving quality of li ...
-
Keynote
This session is sponsored and delivered by Teva UK Limited.
Teva UK Limited have had no input into the speakers or content for the remaining agenda.
-
Improving early detection and diagnosis
-
Advanced cancer treatments and technologies
Proton radiotherapy is a novel state of the art particle therapy and offers the opportunity to deliver highly targeted radiation, but we need to undertake research to understand who are the best candi ...
-
Transforming cancer care pathways
Active monitoring, or watch and wait, is used where cancer patients do not need immediate treatment. For the treatment of chronic lymphocytic leukaemia (CLL), this ensures treatment is given at the op ...
-
Keynote
Immuno-Oncology Therapies are delivering significant patient benefits across increasing tumour indications. However, rapidly growing demand, service variation, and managing immune reactions represent ...
-
Advanced cancer treatments and technologies
Until now no adjuvant or neoadjuvant therapies exist for non-metastatic renal cancer with a high risk of relapse. Previous studies using targeted therapy were not practice-changing. Immune checkpoint ...
-
Transforming cancer care pathways
In support of both earlier diagnosis and response to the covid-19 pandemic the Thames Valley cancer alliance launched the FIT (faecel immunochemical test) in primary care pathway. This session will ex ...
Speakers
-
Improving early detection and diagnosis
•Highlight the challenges that cancer services face following COVID 19 disruption •Highlight the need to design bespoke AO services - no ‘one size fits all’ •Discuss the experience of using technology ...
Speakers
-
Improving early detection and diagnosis
The session will discuss the lessons learnt from the South East London RDC to date. The session will look at the clinic set up, pathways, results to date and future goals.
-
Advanced cancer treatments and technologies
-
Keynote
A discussion of the impact of CAT on cancer patients and the uneven approach to patient information seen in the national health system. The latest guidance recommendations and helpful tools to enhance ...
-
Transforming cancer care pathways
Providing patients with appropriate treatment options at the right time in their disease is key. Professor of Gastroenterology, Mark Pritchard and NET Clinical Nurse Specialist, Wendy Martin will disc ...
-
Keynote
This session will discuss the implications of the 'Integration and Innovation' white paper on cancer care in England, including the vital role of cancer alliances, the implications of changes to speci ...
-
Improving early detection and diagnosis
10 Jun 2021
-
Keynote
Key reflections of the covid pandemic & lessons learnt
-
Keynote
This session is sponsored and delivered by Teva UK Limited.
Teva UK Limited have had no input into the speakers or content for the remaining agenda.
-
Improving early detection and diagnosis
As we all know, there is a short window of opportunity to diagnose lung cancer early, as it develops and, in many cases, progresses quickly. A cornerstone of achieving better outcomes for lung cancer ...
-
Advanced cancer treatments and technologies
In recent times, there has been unprecedented interest in diagnostic technologies and the benefits they can offer to patients and the NHS. With its recent launch of the new NICE strategy, NICE has ren ...
-
Transforming cancer care pathways
For decades, it’s been recognised that the process of noticing a symptom and seeking advice is complex and that people do not always present for medical attention in a timely fashion. This has underpi ...
-
Keynote
Presentation on overall survival for patients with BRAF V600E mutant metastatic colorectal cancer. Implications of the BEACON CRC trial and Insights from real-world experience. A recorded webinar from ...
-
Advanced cancer treatments and technologies
Whilst there are a number of current and potential game changers, we will look at chimeric antigen receptor T-cells (CAR-T) and neoantigen reactive T-cells (NAR-T).
-
Advanced cancer treatments and technologies
A major focus of the NHS Long term plan is to improve cancer survival through prevention, early detection and delivering more personalised therapeutic options and overall care The British Oncology Pha ...
-
Transforming cancer care pathways
Developing and delivering an Alliance wide primary care strategy towards the delivery of the NHS Long Term Plan
-
Advanced cancer treatments and technologies
Gene-guided clinical management is rapidly becoming the new standard of cancer care in the NHS. The session features prediction of cancer risk, precision diagnosis, drug-metabolizing genotypes, the mo ...
-
Improving early detection and diagnosis
The presentation will provide an overview of:Who RM Partners are and the brief/mandate of cancer alliancesThe local context within which RMP works RMP approach to working with and collaborating with p ...
-
Transforming cancer care pathways
By 2030, there will be 4m people in the UK living with cancer with over 50% surviving more than 10 years. The high prevalence of physical and psychosocial effects pose important challenges for our hea ...
-
Keynote
With the development of Integrated Care Systems, the accelerated collaboration that has come with the Covid response and the evolving idea of ‘Population Health Management’, the opportunities to impro ...
09 Jun 2021
-
KeynoteDelivering our Long Term Plan commitments and completing the job of pandemic recovery are two sides of the same coin – both require cancers being identified faster and earlier, improving quality of li ...
-
Keynote
This session is sponsored and delivered by Teva UK Limited.
Teva UK Limited have had no input into the speakers or content for the remaining agenda.
-
Improving early detection and diagnosis
-
Advanced cancer treatments and technologiesProton radiotherapy is a novel state of the art particle therapy and offers the opportunity to deliver highly targeted radiation, but we need to undertake research to understand who are the best candi ...
-
Transforming cancer care pathways
Active monitoring, or watch and wait, is used where cancer patients do not need immediate treatment. For the treatment of chronic lymphocytic leukaemia (CLL), this ensures treatment is given at the op ...
-
Keynote
Immuno-Oncology Therapies are delivering significant patient benefits across increasing tumour indications. However, rapidly growing demand, service variation, and managing immune reactions represent ...
-
Advanced cancer treatments and technologiesUntil now no adjuvant or neoadjuvant therapies exist for non-metastatic renal cancer with a high risk of relapse. Previous studies using targeted therapy were not practice-changing. Immune checkpoint ...
-
Transforming cancer care pathwaysIn support of both earlier diagnosis and response to the covid-19 pandemic the Thames Valley cancer alliance launched the FIT (faecel immunochemical test) in primary care pathway. This session will ex ...Speakers
-
Improving early detection and diagnosis
•Highlight the challenges that cancer services face following COVID 19 disruption •Highlight the need to design bespoke AO services - no ‘one size fits all’ •Discuss the experience of using technology ...Speakers
-
Improving early detection and diagnosisThe session will discuss the lessons learnt from the South East London RDC to date. The session will look at the clinic set up, pathways, results to date and future goals.
-
Advanced cancer treatments and technologies
-
Keynote
A discussion of the impact of CAT on cancer patients and the uneven approach to patient information seen in the national health system. The latest guidance recommendations and helpful tools to enhance ...
-
Transforming cancer care pathways
Providing patients with appropriate treatment options at the right time in their disease is key. Professor of Gastroenterology, Mark Pritchard and NET Clinical Nurse Specialist, Wendy Martin will disc ...
-
KeynoteThis session will discuss the implications of the 'Integration and Innovation' white paper on cancer care in England, including the vital role of cancer alliances, the implications of changes to speci ...
-
Improving early detection and diagnosis
10 Jun 2021
-
KeynoteKey reflections of the covid pandemic & lessons learnt
-
Keynote
This session is sponsored and delivered by Teva UK Limited.
Teva UK Limited have had no input into the speakers or content for the remaining agenda.
-
Improving early detection and diagnosisAs we all know, there is a short window of opportunity to diagnose lung cancer early, as it develops and, in many cases, progresses quickly. A cornerstone of achieving better outcomes for lung cancer ...
-
Advanced cancer treatments and technologiesIn recent times, there has been unprecedented interest in diagnostic technologies and the benefits they can offer to patients and the NHS. With its recent launch of the new NICE strategy, NICE has ren ...
-
Transforming cancer care pathwaysFor decades, it’s been recognised that the process of noticing a symptom and seeking advice is complex and that people do not always present for medical attention in a timely fashion. This has underpi ...
-
Keynote
Presentation on overall survival for patients with BRAF V600E mutant metastatic colorectal cancer. Implications of the BEACON CRC trial and Insights from real-world experience. A recorded webinar from ...
-
Advanced cancer treatments and technologiesWhilst there are a number of current and potential game changers, we will look at chimeric antigen receptor T-cells (CAR-T) and neoantigen reactive T-cells (NAR-T).
-
Advanced cancer treatments and technologies
A major focus of the NHS Long term plan is to improve cancer survival through prevention, early detection and delivering more personalised therapeutic options and overall care The British Oncology Pha ...
-
Transforming cancer care pathwaysDeveloping and delivering an Alliance wide primary care strategy towards the delivery of the NHS Long Term Plan
-
Advanced cancer treatments and technologiesGene-guided clinical management is rapidly becoming the new standard of cancer care in the NHS. The session features prediction of cancer risk, precision diagnosis, drug-metabolizing genotypes, the mo ...
-
Improving early detection and diagnosisThe presentation will provide an overview of:Who RM Partners are and the brief/mandate of cancer alliancesThe local context within which RMP works RMP approach to working with and collaborating with p ...
-
Transforming cancer care pathways
By 2030, there will be 4m people in the UK living with cancer with over 50% surviving more than 10 years. The high prevalence of physical and psychosocial effects pose important challenges for our hea ...
-
Keynote
With the development of Integrated Care Systems, the accelerated collaboration that has come with the Covid response and the evolving idea of ‘Population Health Management’, the opportunities to impro ...
